Literature DB >> 7944297

Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease.

M Leon-Monzon1, I Illa, M C Dalakas.   

Abstract

To investigate the mechanism of polymyositis in human T-cell leukemia virus type I (HTLV-I) infection, we studied 6 HTLV-I-positive patients, 3 with polymyositis and 3 with adult T-cell leukemia but without clinical signs of muscle disease, by (a) quantitative single or double immunocytochemistry on serial 4-microns-thick muscle biopsy sections using antibodies to lymphocyte subsets, major histocompatibility complex (MHC) antigens, and HTLV-I proteins; (b) polymerase chain reaction using HTLV-I primers in the RNA and DNA extracted from 50 micrograms of muscle tissue or from serial 5-microns-thick fresh-frozen tissue sections; and (c) cocultures of the patients' HTLV-I-positive peripheral blood lymphocytes with their homologous muscles searching for replication of HTLV-I within the myotubes. In the muscle of patients with HTLV-I-associated myopathy, the predominant endomysial cells surrounding healthy muscle fibers were CD8+ cells followed by CD4+ cells and macrophages. MHC-I antigens were ubiquitous in the muscles of all 6 patients, even in those without endomysial inflammation. HTLV-I sequences were amplified from the whole muscle biopsy specimens but the cells harboring viral antigens were rare endomysial macrophages and not muscle fibers. Although HTLV-I sequences were amplified from all the patients' peripheral blood lymphocytes, these cells did not exert myotoxicity or resulted in viral replication in cocultures with their homologous myotubes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944297     DOI: 10.1002/ana.410360414

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.

Authors:  H Valentin; I Lemasson; S Hamaia; H Cassé; S König; C Devaux; L Gazzolo
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

3.  SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis.

Authors:  Neva B Watson; Karin M Schneider; Paul T Massa
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

4.  Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).

Authors:  F Mortreux; M Kazanji; A S Gabet; B de Thoisy; E Wattel
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 6.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  In situ polymerase chain reaction detection of HTLV-I provirus and expression of the p53 tumor suppressor gene in infiltrating cells in skeletal muscle from a patient with adult T cell leukemia.

Authors:  I Higuchi; K Hashimoto; N Kashio; S Izumo; H Matsuoka; M Nakagawa; M Osame
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells.

Authors:  Noriko Hironaka; Kanako Mochida; Naoki Mori; Michiyuki Maeda; Naoki Yamamoto; Shoji Yamaoka
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

9.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Nonbacterial myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.